Golden
Simpatica Medicine

Simpatica Medicine

Simpatica Medicine is an AI company founded in 2015 and based in San Francisco, California, that built a Cloud AI for the purpose of interpreting the ability of individual patients to respond to therapeutics in order to guide precision treatments for cancer immune therapies and auto-immune disease.

The purpose of the Simpatica Medicine system is to improve treatment selection for patients and avoid loss of response and or negative side effects. Using RNA Seq measurements to measure the activity of tens of thousands of immune system related genes in parallel, a profile of an individual patient’s immune system is generated. The founders of Simpatica Medicine founded SF17 Therapeutics, another company that uses AI for precision medicine therapeutics, in 2018.

Timeline

People

Name
Role
Related Golden topics

David Ott

Co-Founder, CTO



Jason Barbour

Co-Founder, CEO



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References